Emergomyces africanus in soil, South Africa by Schwartz, Ilan S et al.
 
 
Emergomyces africanus in Soil, South Africa
Schwartz, Ilan S; Lerm, Barbra; Hoving, J Claire; Kenyon, Chris; Horsnell, William; Basson, W
Joan; Otieno-Odhiambo, Patricia; Govender, Nelesh P; Colebunders, Robert; Botha, Alfred
DOI:
10.3201/eid2402.171351
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Schwartz, IS, Lerm, B, Hoving, JC, Kenyon, C, Horsnell, WG, Basson, WJ, Otieno-Odhiambo, P, Govender, NP,
Colebunders, R & Botha, A 2018, 'Emergomyces africanus in Soil, South Africa', Emerging infectious diseases,
vol. 24, no. 2, pp. 377-380. https://doi.org/10.3201/eid2402.171351
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 07/02/2018
Schwartz IS, Lerm B, Hoving J, et al. Emergomyces africanus in Soil, South Africa. Emerging Infectious Diseases. 2018;24(2):377-380.
doi:10.3201/eid2402.171351.
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
Ilan S. Schwartz, Barbra Lerm, J. Claire Hoving, 
Chris Kenyon, William G. Horsnell,  
W. Joan Basson, Patricia Otieno-Odhiambo, 
Nelesh P. Govender, Robert Colebunders,  
Alfred Botha
We detected Emergomyces africanus, a thermally dimor-
phic fungus that causes an HIV-associated systemic my-
cosis, by PCR in 18 (30%) of 60 soil samples from a wide 
range of habitats in South Africa. Direct and indirect culture 
techniques were unsuccessful. Experimental intraperitoneal 
inoculation of conidia induced murine disease.
The newly described thermally dimorphic fungal genus Emergomyces comprises human pathogens that cause 
systemic mycoses in immunocompromised persons glob-
ally (1). Among these fungi, Emergomyces africanus (for-
merly Emmonsia sp. [2]) is the species responsible for the 
most human disease. HIV-associated emergomycosis is the 
most common endemic mycosis in South Africa and is as-
sociated with a high case-fatality ratio (3,4).
Although an environmental reservoir for Es. africanus 
has not been established, soil is presumed to harbor the 
mycelial phase (2). We tested soils in South Africa for Es. 
africanus by using molecular- and culture-based methods.
The Study
We collected 60 soil samples from various soil habitats 
around South Africa by convenience sampling; 82% per-
cent of samples came from the Western Cape Province, 
with the remaining samples from Gauteng (7%), Eastern 
Cape (7%), KwaZulu-Natal (2%), and Northern Cape (2%) 
provinces. For each sample, we used sterile, plastic tubes to 
collect ≈100 mL of topsoil.
We extracted DNA from soil by using the ZR Soil 
Microbe DNA Miniprep Kit (Zymo Research, Irvine, CA, 
USA). DNA extraction was successful for 56 soil samples 
(93%). We subjected extracted genomic DNA (gDNA) to 
a nested PCR. To amplify the internal transcribed spacer 
(ITS) region of the ribosomal RNA, we used the universal 
primers ITS1 and ITS4 in the first reaction (5). We used 
an Applied Biosystems 2720 Thermal Cycler (Foster City, 
CA, USA); thermocycling conditions consisted of 95°C 
for 5 min, 30 cycles of 95°C for 30 s, 52°C for 30 s, 72°C 
for 45 s, and 72°C for 7 min. We subjected PCR products 
to amplification by using Es. africanus–specific primers 
(forward, 5′-CCTGGTTTGGGGAGAGGGGT-3′; re-
verse, 5′-CCGGGGGAGCTCTTGGCTCT-3′), followed 
by electrophoresis on a 2% agarose gel. We performed 
amplification as described, except with an annealing 
temperature of 57°C. PCR mixtures consisted of 10 µL 
2× KAPA Taq ReadyMix (KAPA Biosystems, Wilm-
ington, MA, USA); 1 µL of each primer (10 µmol/L; 
Inqaba Biotechnical Industries, Pretoria, South Africa); 
and 1 µL of extracted gDNA or ITS PCR product, in a 
final reaction volume of 20 µL. We sequenced amplified 
products and compared them using BLAST (https://blast.
ncbi.nlm.nih.gov/Blast.cgi). The PCR could detect as 
few as 102–104 conidia/10 g of soil (online Technical 
Appendix, https://wwwnc.cdc.gov/EID/article/24/2/17-
1351-Techapp1.pdf).
We plotted results of molecular testing and residential 
postal codes of persons with confirmed infections (Figure 
1). We detected Es. africanus DNA in 18 (32%) of 56 soil 
samples representing all types of soil habitats tested (Table).
We used soil dilution plates prepared with Sabouraud 
agar (40 g/L glucose [Merck, Darmstadt, Germany], 10 
g/L peptone [Merck], and 15 g/L agar) supplemented with 
0.2 g/L chloramphenicol (Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany) to culture Es. africanus from 4 ran-
domly selected soil samples. We incubated the resulting 
spread plates at 26°C, inspecting plates daily for 1 week 
and then twice weekly for an additional 3 weeks. All cul-
ture plates were rapidly overgrown by filamentous fungi 
other than Es. africanus.
To overcome rapid contamination, we used indi-
rect culture methods. First, we used the flotation method 
adapted from Larsh et al. (7) to separate the conidia from 
other particles in the soil (online Technical Appendix). We 
plated the resulting soil suspensions on Sabouraud agar 
and brain heart infusion (BHI) plates and incubated them 
at 26°C, conducting daily examinations for fungal colonies 
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DISPATCHES
resembling Es. africanus (1). This preparation also resulted 
in rapid contamination of all plates.
Thereafter, we passaged soil suspensions through 
mice to screen out nonpathogenic soil organisms (8; online 
Technical Appendix). Animal studies were approved by the 
University of Cape Town’s Animal Ethics Committee (pro-
tocol 016–002). We created soil suspensions by using the 
flotation method and sampling from the bottom third of the 
column; penicillin G (1,000 IU/mL) and gentamicin (0.1 
mg/mL) were included in the solution. We inoculated 1 mL 
of soil suspension intraperitoneally into each of 4 BALB/c 
or C57BL6 mice. We euthanized the mice after 2 weeks 
and plated livers, spleens, or both onto Sabouraud agar 
plates with and without chloramphenicol, which we then 
incubated at 30°C and 35°C–37°C. We inspected plates as 
described previously. Pilot studies demonstrated that this 
method could detect as few as 102 conidia in 10 g of soil 
(online Technical Appendix). Notably, in a pilot study in 
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Figure 1. Results of molecular 
tests for the presence of 
Emergomyces africanus in soil 
samples in relation to residential 
locations of 14 patients 
diagnosed with emergomycosis 
(6), Cape Peninsula, Western 
Cape Province, South Africa. 
Black circles indicate Es. 
africanus detected in soil 
sample; white circles indicate 
Es. africanus not detected in 
soil sample; plus signs indicate 
residential locations of patients 
with emergomycosis. A larger 
cross indicates >1 infected 
patient at that particular location.
 
Table. Results of molecular-based detection of Emergomyces africanus in 60 soil samples, by province and type of soil habitat, South 
Africa* 
Soil habitat Western Cape Eastern Cape Gauteng KwaZulu-Natal Northern Cape Total 
Garden 6/30 0/2 1/4 – – 7/36 
Agricultural 3/5 – – – – 3/5 
Compost 3/5 – – – – 3/5 
Disturbed 1/2 0/2 – 0/1 – 2/5 
Fynbos 1/2 – – – – 1/2 
Veld 1/1 0/1 – – 0/1 1/3 
Rotting tree 1/1 – – – – 1/1 
Unknown 1/3 – – – – 1/3 
Total 17/49 0/4 1/4 0/1 0/1 18/60 
*Data represent number of samples in which Es. africanus was detected by nested PCR/total number of samples. Soil habitats: garden, soil from private 
gardens; agricultural, soil used for farming purposes; compost, soil rich in compost; disturbed, nutrient-poor uncultivated soil subjected to anthropogenic 
activities; fynbos, soil from a natural indigenous vegetation type endemic to the Cape Floristic region; veld, soil from grassland or uncultivated land; rotting 
tree, decaying woody debris; unknown, soil from unknown origin. –, sample not taken. 
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which BALB/c and C57BL/6 mice were challenged with 
graded doses of Es. africanus conidia, genetic background 
of mice influenced host susceptibility to the organism; 
C57BL/6 mice were more sensitive to infection and had 
significantly higher mortality and weight loss in response 
to the high dose of 106 conidia compared with BALB/c 
mice (Figure 2).
We screened 26 soil samples for the presence of Es. 
africanus by using mouse passage. These samples included 
all 18 soil samples in which Es. africanus was detected by 
nested PCR, as well 8 soil samples that were PCR-negative. 
None of these samples, however, led to the isolation of Es. 
africanus through mouse passage. 
Conclusions
Es. africanus is a newly described dimorphic fungal patho-
gen and causes an important HIV-associated systemic my-
cosis in South Africa (9). Many aspects of this organism 
remain unknown, including its ecologic niche. Our findings 
demonstrate that Es. africanus is present in a high propor-
tion of soil samples collected from a range of habitats in 
South Africa, suggesting that soil might be a natural reser-
voir for this pathogen.
The isolation of pathogenic fungi from soil is chal-
lenging. Soil naturally contains a vast array of bacteria, 
viruses, fungi, and protozoa, all of which can interfere 
with or contaminate culturing the organism of interest 
(8). Since 1932, when Stewart and Meyer first cultured 
Coccidioides immitis from soil (10), flotation and animal 
passage has been the most robust method to isolate patho-
genic fungi from soil. However, animal passage is labori-
ous and expensive, can take months of turnaround time, 
requires special animal facilities, and results in discom-
fort and loss of life to laboratory animals, necessitating 
stringent ethics review (11).
Molecular detection is a valuable tool for establishing 
the presence of genetic material in environmental samples 
(11). In addition to high sensitivity, molecular detection 
has the advantages of being easy to apply, inexpensive, 
and rapid, and it can be performed in most laboratories. 
Alternatively, molecular detection lacks specificity because 
it cannot determine the viability (and hence infectivity) of 
the detected target (11). In our study, mouse passage of soil 
samples shown by nested PCR to contain Es. africanus ge-
netic material did not result in the isolation of this fungus.
We have demonstrated that experimental infection 
with Es. africanus can produce pathology in mice. More-
over, susceptibility to disease appears to be mouse strain–
dependent, with C57BL/6 mice being more susceptible 
than BALB/c mice.
This study has some limitations. The number of 
samples, and especially those from outside Western Cape 
Province, was relatively small, limiting inferences about 
the geographic range of Es. africanus in the environment. 
Moreover, our method of convenience sampling is prone 
to sampling bias. Nonetheless, this study is instructive 
for future ecologic studies, which should use random 
sampling to refine knowledge of the ecologic niche of 
this fungus.
In conclusion, this study demonstrates that Es. africa-
nus can be frequently detected in a wide range of soils in 
South Africa. Moreover, our findings support the hypoth-
esis that soil serves as a reservoir for this pathogen.
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Figure 2. Infection of mice 
with Emergomyces africanus. 
In a proof-of-principle study, 
C57BL/6 and BALBc mice were 
inoculated intraperitoneally 
with 106 conidia (Es. africanus 
CAB 2141, a clinical isolate) 
in saline. Mice were weighed 
and monitored twice daily 
for distress. Both mouse 
strains had symptom onset, 
with C57BL/6 mice showing 
significantly more severe 
disease pathophysiology in 
response to the high dose of Es. africanus (demonstrated by reduced survival and increased weight loss). Data represent 2 pooled 
experiments (n = 8 [panel A] and n = 2 [panel B] combined), mean +SD of the mean. p values were determined by using unpaired 
2-tailed Student t-test or 1-way analysis of variance using a Bonferroni posttest (GraphPad Prism version 5). Values of p<0.05 were 
considered significant. *p<0.05; **p<0.01; ***p<0.001 (C57BL/6 compared with BALB/c mice).
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